Opexa Therapeutics (OPXA) to Participate at UBS Global Life Sciences Conference  
9/18/2012 8:54:07 AM

THE WOODLANDS, Texas--(BUSINESS WIRE)--Opexa Therapeutics, Inc. (NASDAQ:OPXA), a company developing Tcelnaâ„¢, a novel T-cell therapy for multiple sclerosis (MS), today announced that Neil Warma, President and Chief Executive Officer, will attend the upcoming UBS Global Life Sciences Conference. The event is being held September 19-20, 2012 at the Grand Hyatt in New York City.